Business Description
Founded in 2013 and headquartered in Luxembourg, Alvotech develops and manufactures biosimilar medicines designed to be more affordable alternatives to established biologic drugs. The company's portfolio targets a range of serious conditions, including inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis, as well as eye conditions, bone disorders, certain cancers, and respiratory allergies. Alvotech supplies these medicines to patients across the world through its subsidiaries and commercial partners.
